# Determining Cell- and Spatially-distinct Skeletal Muscle Transcriptional Aberrations in Insulin Resistance

> **NCT07516509** · — · NOT_YET_RECRUITING · sponsor: **AdventHealth Translational Research Institute** · enrollment: 36 (estimated)

## Conditions studied

- Insulin Resistance

## Interventions

- **OTHER:** VO2 Max
- **OTHER:** DEXA
- **OTHER:** Peripheral Microvascular Reactivity
- **OTHER:** Skeletal Muscle Insulin Sensitivity
- **OTHER:** Non-Oxidative Glucose Disposal
- **OTHER:** Muscle tissue Biopsy

## Key facts

- **NCT ID:** NCT07516509
- **Lead sponsor:** AdventHealth Translational Research Institute
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-06
- **Primary completion:** 2028-12
- **Final completion:** 2028-12
- **Target enrollment:** 36 (ESTIMATED)
- **Last updated:** 2026-04-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07516509

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07516509, "Determining Cell- and Spatially-distinct Skeletal Muscle Transcriptional Aberrations in Insulin Resistance". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07516509. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*